Non Hodgkin Lymphoma Clinical Trial

CB-Long-Term Safety Study (CB-LTSS)

Summary

This is a non-interventional, long-term safety study of allogeneic CAR-T cell therapy in patients with hematologic malignancies. Its purpose of is to collect long-term observational data to identify and understand potential late side effects in patients who have received CAR-T cell therapies.

View Full Description

Full Description

This is a non-interventional, long-term safety study of allogeneic CAR-T cell therapy in patients with hematologic malignancies. The purpose of this 15-year research study is to collect long-term observational data to identify and understand potential late side effects in patients who have received CAR-T cell therapies as part of a previous Caribou-sponsored study or a Caribou-sponsored special access program.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Written informed consent obtained prior to study-specific activities/enrollment
Received an allogeneic CAR-T therapy and completed or discontinued from a Caribou-sponsored study evaluating an allogeneic CAR-T therapy or was administered an allogeneic CAR-T therapy under a special access mechanism

Exclusion Criteria:

None

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

100

Study ID:

NCT05332054

Recruitment Status:

Enrolling by invitation

Sponsor:

Caribou Biosciences, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

University of California Irvine
Irvine California, 92868, United States
Oncology Hematology Care
Cincinnati Ohio, 45242, United States
Baylor Research Institute
Dallas Texas, 75246, United States
MD Anderson Cancer Center
Houston Texas, 77030, United States

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

100

Study ID:

NCT05332054

Recruitment Status:

Enrolling by invitation

Sponsor:


Caribou Biosciences, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.